Q1 2015

Filed May 15, 2015 · 10-Q · 45 days after period end · 0001437749-15-010410

Q1 2015 · 10-Q

Revenue

$26.67K

+187.2% vs Q1 2014

Net Income

-$780.43K

N/M vs Q1 2014

EPS Diluted

-$0.01

N/M vs Q1 2014

Gross Profit$7,494+10.9%

Operating Income

Same quarter

Metric	Q1 2015	Q1 2014	Q1 2013	Q1 2012
Revenue	$26.67K	$9.29K	$14.36K	$30.82K
Net Income	-$780.43K	-$1.02M	-$645.30K	-$920.97K
EPS Diluted	-$0.01	-$0.01	-$0.01	-$0.02

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Biolargo, Inc. · CIK 880242 · Engraved from SEC EDGAR